Want to track LSTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lisata Therapeutics Inc. (LSTA) Statistics
Valuation metrics
Market Cap 32.1M
Enterprise value 2.15M
Trailing P/E (ttm) -0.9
Forward P/E -2.71
PEG ratio -0.04
Price/Sales (ttm) 89.46
Price/Book (mrq) 1.38
Enterprise Value/Revenue 12.63
Enterprise Value/EBITDA -0.13
Overview
Shares outstanding 9.11M
Float 7.19M
Shares short 70.25K
% Held by insiders 0.21%
% Held by institutions 0.11%
Average volume (10 days) 133.69K
Average volume (90 days) 108.61K
Price summary
52-Week low 1.43
52-Week high 5.07
Beta 1.11
50-Day moving average 3.29
200-Day moving average 3.89
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 15 Sep 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -96.18%
Operating margin -101.78%
Operational effectiveness
Return on assets -1.16%
Return on equity -1.02%
Income Statement
Revenue (ttm) 170K
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) 170K
EBITDA -17.2M
Net income to common (ttm) -16.35M
Diluted EPS (ttm) -1.82
Quarterly earnings growth (yoy) -0.9%
Balance Sheet
Total cash (mrq) 13.06M
Total cash per share (mrq) 1.45
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 4.23%
Book value per share (mrq) 1.18
Cash Flow
Cash flow statement -13.63M
Levered free cash flow (LFCF) -8.06M
